Navigation Links
Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
Date:3/22/2013

HAYWARD, Calif., March 22, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced its abstract entitled "Blisibimod, an Emerging Subcutaneous Biologic Therapy for Patients with Active, Moderate-to-Severe Systemic Lupus Erythematosus," has been selected as an oral presentation and will be presented at the 10th International Congress on Systemic Lupus Erythematosus by Dr. Morton Scheinberg , a rheumatologist at the Hospital Abreu Sodre Pesquisa Clinica in Sao Paulo, Brazil, on April 20, 2013.

Additionally, a poster entitled "Clinical Experience in Latin America With Blisibimod Amongst Subjects with Active, Moderate-to-Severe Systemic Lupus Erythematosus: Data From The Phase 2b PEARL-SC Study," will be presented by Dr. Scheinberg as part of the conferences Guided Poster Tours on April 19, 2013.

The poster will be available on www.anthera.com.

About Blisibimod and PEARL-SC

BAFF has been associated with a wide range of B-cell-mediated autoimmune diseases, including systemic lupus erythematosus, vasculitis, IgA nephropathy, immune thrombocytopenic purpura and others. Multiple clinical studies with other BAFF antagonists recently have reported on BAFF inhibitors potential positive role in treating lupus and rheumatoid arthritis. Anthera is advancing its development of blisibimod, a selective inhibitor of BAFF, to expand its potential clinical utility in autoimmune diseases. Blisibimod is a novel fusion protein called a peptibody and is distinct from an antibody. Anthera owns worldwide rights to blisibimod in all potential indications.  The PEARL-SC Phase 2 study was designed as a ran
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
2. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
3. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
4. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
5. Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
6. Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting
7. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
8. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)
9. Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update
10. Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
11. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015 Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, today announced that it will release ... 10, 2015 after the close of the U.S. financial ... webcast on Monday, August 10, 2015 at 4:30 p.m. ... and corporate developments. For both "listen-only" participants ...
(Date:7/29/2015)... Calif. , July 29, 2015  Depomed, ... today announced that its Board of Directors, after ... independent financial and legal advisors, has unanimously rejected ... proposal from Horizon Pharma plc (NASDAQ: HZNP ... shares of Depomed in an all-stock transaction (the ...
(Date:7/29/2015)... July 29, 2015 Immune Pharmaceuticals Inc. (NASDAQ: ... of up to $21.5 million through two financing agreements. ... HTGC ) ("Hercules"), for a term loan of up ... Discover Growth Fund ("Discover"), for the sale to Discover ... ("Preferred Stock") for up to $12 million in gross ...
Breaking Medicine Technology:Asterias Biotherapeutics to Report Second Quarter Results on August 10, 2015 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 6Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 7
... with Scripps Florida and Scripps Research in La ... ... FRANCISCO, Calif., and LA JOLLA, Calif., May 14 /PRNewswire-,FirstCall/ -- Poniard ... and The Scripps Research,Institute, a non-profit biomedical research organization, today announced,that ...
... DOYLESTOWN, Pa., May 14 The Quigley,Corporation (Nasdaq: ... study,conducted by its wholly owned subsidiary, Quigley Pharma ... anti-viral activity of its compound,QR448(a). The compound was ... Bronchitis Virus (IBV). The data from the study ...
Cached Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5
(Date:7/30/2015)... ... July 30, 2015 , ... PeopleKeys, a company with over 30 ... Train the Trainer” webinar. The webinar, the newest installment in their popular DISC for ... The Managing Stress: Train the Trainer webinar is intended for people interested in training ...
(Date:7/29/2015)... ... 30, 2015 , ... Drs. Hamstead are very excited to announce the expansion ... the offerings in the clinic; massage therapy works very well alongside chiropractic care to ... has joined AlignLife of Simpsonville to work alongside the doctors. Many people can benefit ...
(Date:7/29/2015)... ... ... to an article published July 23 by the Daily Mail, a new online ... needs to do in terms of physical activity and caloric intake to lose weight. Based ... the number of calories a person needs to consume to maintain or lose weight at ...
(Date:7/29/2015)... California (PRWEB) , ... July 29, 2015 , ... Conventional ... sell, and trade goods and services may be able to unlock mysteries about the ... Claremont Graduate University , Boston University, and Columbia University. , The findings, published July ...
(Date:7/29/2015)... Richey, FL (PRWEB) , ... July 29, 2015 ... ... nation have become increasingly aware of the impact drinking and substance abuse is ... increased illness. Financial loss is tagged in the billions per year. [1] Will ...
Breaking Medicine News(10 mins):Health News:PeopleKeys to Air “Managing Stress: Train the Trainer” DISC Webinar 2Health News:AlignLife of Simpsonville Hires Massage Therapist 2Health News:New NIH Body Weight Planner Illustrates the Need for Reduced Caloric Intake When Trying to Lose Weight, Says Beverly Hills Physicians 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 2Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 3
... Outlines Ways to Lower Costs and Expand Health Coverage for More ... HMS , the nation,s leader in cost management ... to Congress for reducing healthcare costs while expanding coverage under ... (CHIP), and other government programs. , , "In ...
... of GERD complications in any United States general ... thought that such complications occur less frequently in ... in Jacksonville, FL investigated the prevalence of reflux ... of esophagitis severity and its complications were equivalent ...
... Winners Demonstrates Strong Employer Commitment , to Workplace Health & ... The National Business Group on Health (NBGH) is pleased ... of the U.S. economy -- have been recognized as "2009 ... their exceptional commitment to a healthy workplace and for helping ...
... LAKE CITY, June 24 Dynatronics Corporation (Nasdaq: ... new V-Force Vibration Therapy units to customers. These new ... training to increase strength, improve balance and enhance flexibility. ... program to compensate for bone and muscle loss resulting ...
... attendees hands-on experience , , RESEARCH TRIANGLE PARK, N.C., ... manufacturer of bone tissue regeneration and dental implant products, has ... in Chicago Friday, July 24th from 8:00 am to 4:00 ... information on bone grafting materials and methods, and hands-on experience ...
... aging, but good habits can help you cope, experts say ... off the mental decline associated with old age, engage in ... your social life. , Those are the findings of ... aging and the brain. , The review, which spanned three ...
Cached Medicine News:Health News:HMS Urges Healthcare Reform Measures to Manage Costs, Target Resources, Fight Fraud 2Health News:What is different in reflux esophagitis between African-Americans and non-Hispanic whites? 2Health News:National Business Group on Health Recognizes 63 Large Employers as '2009 Best Employers for Healthy Lifestyles' Award Winners 2Health News:National Business Group on Health Recognizes 63 Large Employers as '2009 Best Employers for Healthy Lifestyles' Award Winners 3Health News:Dynatronics Begins Shipping New V-Force Vibration Therapy Units 2Health News:Dynatronics Begins Shipping New V-Force Vibration Therapy Units 3Health News:RIEMSER Announces Upcoming Chicago Bone Grafting Workshop 2Health News:Stay Upbeat, Active to Keep the Mind Young 2Health News:Stay Upbeat, Active to Keep the Mind Young 3
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
GenuTrain P3 is a support that centers the patella during joint movement....
... knee brace provides maximum support ... of sports and activities. Geared ... pads to support medial and ... and hyperextension stop. 3/16" thick, ...
... Knee Brace features an adjustable extension/flexion ... 135 in 10 increments. Adjust without ... expose the stop pins and reposition ... self-padded washable fabric with Velcro fasteners. ...
Medicine Products: